Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

Mads Ravnborg, Per Soelberg Sørensen, Magnus Andersson, Elisabeth G Celius, Peter J Jongen, Irina Elovaara, Emmanuel Bartholomé, Cris S Constantinescu, Karsten Beer, Ellen Garde, Bjørn Sperling

73 Citationer (Scopus)

Abstract

Interferon beta is commonly used to treat patients with relapsing-remitting multiple sclerosis; however, the treatment is only partially effective in reducing relapses and progression of disability. Corticosteroids are used to treat relapses in patients with multiple sclerosis. We therefore aimed to investigate the combination of cyclic methylprednisolone and interferon beta for the treatment of relapsing-remitting multiple sclerosis.
OriginalsprogEngelsk
TidsskriftLancet neurology
Vol/bind9
Udgave nummer7
Sider (fra-til)672-80
Antal sider9
ISSN1474-4422
DOI
StatusUdgivet - 1 jul. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om 'Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial'. Sammen danner de et unikt fingeraftryk.

Citationsformater